Association between obesity and frequency of high-grade prostate cancer on biopsy in men: A single-center retrospective study.

body mass index high-grade prostatic disease prostate cancer

Journal

Molecular and clinical oncology
ISSN: 2049-9469
Titre abrégé: Mol Clin Oncol
Pays: England
ID NLM: 101613422

Informations de publication

Date de publication:
Aug 2022
Historique:
received: 06 01 2022
accepted: 24 02 2022
entrez: 14 7 2022
pubmed: 15 7 2022
medline: 15 7 2022
Statut: epublish

Résumé

The present study aimed to investigate the relationship between BMI and the prostate cancer (PCa) risk at biopsy in Italian men. Retrospective analyses of the clinical data of 2,372 consecutive men undergoing ultrasound-guided multicore (≥10) prostate biopsy transrectally between May 2010 and December 2018 were performed. BMIs were categorized, according to Western countries' classification of obesity, as follows: <18.5 kg/m

Identifiants

pubmed: 35832470
doi: 10.3892/mco.2022.2560
pii: MCO-17-2-02560
pmc: PMC9264326
doi:

Types de publication

Journal Article

Langues

eng

Pagination

127

Informations de copyright

Copyright: © Baio et al.

Déclaration de conflit d'intérêts

The authors declare that they have no competing interests.

Références

Br J Cancer. 2003 Oct 6;89(7):1237-42
pubmed: 14520453
Nat Genet. 2013 Apr;45(4):385-91, 391e1-2
pubmed: 23535732
Cancer Med. 2020 Sep;9(17):6421-6429
pubmed: 32639678
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90
pubmed: 21296855
Public Health. 2005 Aug;119(8):694-8
pubmed: 15949523
BJU Int. 2013 Aug;112(4):E265-71
pubmed: 23432960
Int J Cancer. 1977 Nov 15;20(5):680-8
pubmed: 924691
BJU Int. 2014 Dec;114(6):891-5
pubmed: 24314095
Eur Urol. 2012 Oct;62(4):656-61
pubmed: 22386193
Prostate Cancer Prostatic Dis. 2012 Jun;15(2):135-43
pubmed: 22333686
Asian J Androl. 2013 Nov;15(6):747-52
pubmed: 24036920
N Engl J Med. 2012 Jan 12;366(2):141-9
pubmed: 22236224
JAMA. 2007 Nov 21;298(19):2275-80
pubmed: 18029831
Chang Gung Med J. 2011 Jan-Feb;34(1):1-22
pubmed: 21392470
Lancet. 2014 Aug 30;384(9945):755-65
pubmed: 25129328
J Urol. 2005 Jun;173(6):1935-7
pubmed: 15879785
J Urol. 2006 Feb;175(2):500-4; discussion 504
pubmed: 16406980
Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
Cancer Causes Control. 2006 Oct;17(8):989-1003
pubmed: 16933050
J Natl Cancer Inst. 1997 Mar 5;89(5):385-9
pubmed: 9060961
Cancer Epidemiol Biomarkers Prev. 2009 Mar;18(3):748-51
pubmed: 19258472
Hum Mol Genet. 2015 Oct 1;24(19):5589-602
pubmed: 26025378
Prostate Cancer Prostatic Dis. 2009;12(3):259-63
pubmed: 19581922
Int Urol Nephrol. 2009;41(2):267-72
pubmed: 18665451
BJU Int. 2016 Apr;117(4):576-83
pubmed: 26332304
PLoS One. 2014 Sep 03;9(9):e106677
pubmed: 25184215
Int J Urol. 2013 Jul;20(7):701-7
pubmed: 23186107
Can J Urol. 2008 Feb;15(1):3866-71
pubmed: 18304396
BMC Cancer. 2020 Jun 23;20(1):589
pubmed: 32576177
Cancer. 2006 Nov 15;107(10):2361-7
pubmed: 17031814
Cancer Epidemiol Biomarkers Prev. 2007 Jan;16(1):70-6
pubmed: 17179487
Urology. 2005 Apr;65(4):708-12
pubmed: 15833513
Nat Rev Endocrinol. 2014 Nov;10(11):644-5
pubmed: 25265978
Urology. 2005 Jul;66(1):108-13
pubmed: 15992911
Int J Cancer. 2016 Jun 1;138(11):2579-91
pubmed: 26638190
Med Oncol. 2014 Feb;31(2):829
pubmed: 24390417
J Urol. 2007 Feb;177(2):493-8
pubmed: 17222617
Urology. 2008 Apr;71(4):554-60
pubmed: 18308373
Urology. 2008 May;71(5):787-91
pubmed: 18267334
Cancer Causes Control. 2019 Jan;30(1):13-20
pubmed: 30523509
World J Urol. 2012 Apr;30(2):143-8
pubmed: 22116601
Urology. 2005 Jul;66(1):130-4
pubmed: 16014286
Eur J Cancer. 2007 May;43(7):1180-7
pubmed: 17292604
Prostate Cancer Prostatic Dis. 2007;10(2):137-42
pubmed: 17179979
Clin Epidemiol. 2012;4:1-11
pubmed: 22291478
BJU Int. 2009 Nov;104(10):1457-61
pubmed: 19522868
Cancer. 2005 Mar 1;103(5):1092-5
pubmed: 15668913
Prostate. 2008 Mar 1;68(4):373-80
pubmed: 18189231
Urology. 2010 Nov;76(5):1063-6
pubmed: 20573382
J Clin Oncol. 2016 Jan 1;34(1):91-101
pubmed: 26578615
Eur Urol. 2007 Aug;52(2):331-43
pubmed: 17507151
J Urol. 2009 Jul;182(1):106-10; discussion 110-1
pubmed: 19450837
Prostate. 2006 Sep 15;66(13):1371-80
pubmed: 16752375
Int J Cancer. 2015 Oct 1;137(7):1749-57
pubmed: 25821151
Niger J Surg. 2021 Jan-Jun;27(1):22-27
pubmed: 34012237
N Engl J Med. 2016 Aug 4;375(5):443-53
pubmed: 27433846
Int J Urol. 2009 Jan;16(1):91-5
pubmed: 19054167
Int J Urol. 2007 Nov;14(11):1009-12
pubmed: 17956528

Auteurs

Raffaele Baio (R)

Department of Medicine and Surgery 'Scuola Medica Salernitana', University of Salerno, Baronissi, I-84081 Salerno, Italy.

Giorgio Napodano (G)

Department of Urology, Ospedale del Mare, I-80147 Naples, Italy.

Christian Caruana (C)

Department of Chemistry, University of Malta, Msida MSD2080, Malta.

Giovanni Molisso (G)

Department of Urology, Umberto I Hospital, Nocera, Inferiore, I-84014 Salerno, Italy.

Umberto Di Mauro (U)

Department of Urology, Umberto I Hospital, Nocera, Inferiore, I-84014 Salerno, Italy.

Olivier Intilla (O)

Department of Urology, Umberto I Hospital, Nocera, Inferiore, I-84014 Salerno, Italy.

Umberto Pane (U)

Department of Urology, Umberto I Hospital, Nocera, Inferiore, I-84014 Salerno, Italy.

Costantino D'Angelo (C)

Department of Medical Biotechnologies, University of Siena, I-53100 Siena, Italy.

Antonella Bianca Francavilla (AB)

Department of Civil Engineering, University of Salerno, Fisciano, I-84084 Salerno, Italy.

Claudio Guarnaccia (C)

Department of Civil Engineering, University of Salerno, Fisciano, I-84084 Salerno, Italy.

Francesca Pentimalli (F)

Department of Medicine and Surgery, LUM University, I-70010 Bari, Italy.

Roberto Sanseverino (R)

Department of Urology, Umberto I Hospital, Nocera, Inferiore, I-84014 Salerno, Italy.

Classifications MeSH